Citizen Portal
Sign In

Get Full Government Meeting Transcripts, Videos, & Alerts Forever!

Get email alerts on the Pharmaceutical Distribution topic

No spam. Unsubscribe anytime.

Committee hears bill to ease pharmacy distributor reciprocity for out‑of‑state suppliers

2813715 · March 26, 2025
AI-Generated Content: All content on this page was generated by AI to highlight key points from the meeting. For complete details and context, we recommend watching the full video. so we can fix them.

Summary

Rep. George Ruzah presented House Bill 1465, requested by the state Board of Pharmacy, to allow distributors licensed through national boards to ship pharmaceuticals and devices into Missouri when some other states no longer maintain a state distributor license; witnesses did not oppose.

Representative George Ruzah (District 89) presented House Bill 1465 to a Missouri House committee, saying the bill would permit certain out‑of‑state pharmaceutical and medical device distributors to ship to Missouri residents when the distributor's home state no longer issues a specific state license.

Ruzah said the measure was brought at the request of the Missouri Board of Pharmacy to address a practical problem: some states have discontinued specific distributor licenses because of federal changes, leaving companies in those states unable to meet Missouri's licensing reciprocity requirement. "This bill is being brought forth because they've been faced with a situation where there is a distributor of pharmaceuticals and medical devices in New Jersey that sells products and ships products to Missouri," Ruzah said. "The problem is that the current rules are that in order to do that you have to have a license either in Missouri or a reciprocity with the state that has a license for that distribution."

The bill would reference standards set by the National Association of Boards of Pharmacy (NABP), the organization of state boards that regulates distribution practices, and would allow reciprocity where a comparable national credential exists even if the supplier's home state no longer issues the specific license.

Ruzah said the bill's purpose is to ensure Missouri residents can continue to receive medications and medical devices when federal and state licensing regimes have changed. No opposition testimony was offered during the hearing; the committee moved on after a short question period.

Ending: The committee took the bill under advisement for further consideration; no formal vote was recorded during the hearing.